These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34279025)

  • 21. Prevalence, determinants, and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease.
    Tang H; Gong WY; Zhang QZ; Zhang J; Ye ZC; Peng H; Wang C; Lou T
    Nephrology (Carlton); 2016 Oct; 21(10):841-50. PubMed ID: 26566951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levels of office blood pressure and their operating characteristics for detecting masked hypertension based on ambulatory blood pressure monitoring.
    Viera AJ; Lin FC; Tuttle LA; Shimbo D; Diaz KM; Olsson E; Stankevitz K; Hinderliter AL
    Am J Hypertens; 2015 Jan; 28(1):42-9. PubMed ID: 24898379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subclinical arterial damage in untreated masked hypertensive subjects detected by home blood pressure measurement.
    Matsui Y; Eguchi K; Ishikawa J; Hoshide S; Shimada K; Kario K
    Am J Hypertens; 2007 Apr; 20(4):385-91. PubMed ID: 17386344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current approach to masked hypertension: From diagnosis to clinical management.
    Dolan E; James K
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1272-1278. PubMed ID: 24283851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol.
    Parati G; Agabiti-Rosei E; Bakris GL; Bilo G; Branzi G; Cecchi F; Chrostowska M; De la Sierra A; Domenech M; Dorobantu M; Faria T; Huo Y; Jelaković B; Kahan T; Konradi A; Laurent S; Li N; Madan K; Mancia G; McManus RJ; Modesti PA; Ochoa JE; Octavio JA; Omboni S; Palatini P; Park JB; Pellegrini D; Perl S; Podoleanu C; Pucci G; Redon J; Renna N; Rhee MY; Rodilla Sala E; Sanchez R; Schmieder R; Soranna D; Stergiou G; Stojanovic M; Tsioufis K; Valsecchi MG; Veglio F; Waisman GD; Wang JG; Wijnmaalen P; Zambon A; Zanchetti A; Zhang Y
    BMJ Open; 2018 Dec; 8(12):e021038. PubMed ID: 30573476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary Study.
    Ghazi L; Cohen LP; Muntner P; Shimbo D; Drawz PE
    Hypertension; 2020 Oct; 76(4):1090-1096. PubMed ID: 32829666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence, predictive factor, and clinical significance of white-coat hypertension and masked hypertension in Korean hypertensive patients.
    Hwang ES; Choi KJ; Kang DH; Nam GB; Jang JS; Jeong YH; Lee CH; Lee JY; Park HK; Park CH
    Korean J Intern Med; 2007 Dec; 22(4):256-62. PubMed ID: 18309684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Masked hypertensives: A disguised arterial stiffness population.
    Antza C; Doundoulakis I; Stabouli S; Tziomalos K; Kotsis V
    J Clin Hypertens (Greenwich); 2019 Oct; 21(10):1473-1480. PubMed ID: 31498516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study.
    Sivén SS; Niiranen TJ; Kantola IM; Jula AM
    J Hypertens; 2016 Jan; 34(1):54-60. PubMed ID: 26630213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What a high prevalence of white coat hypertension in society!
    Helvaci MR; Seyhanli M
    Intern Med; 2006; 45(10):671-4. PubMed ID: 16778338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study.
    Fukuhara M; Arima H; Ninomiya T; Hata J; Hirakawa Y; Doi Y; Yonemoto K; Mukai N; Nagata M; Ikeda F; Matsumura K; Kitazono T; Kiyohara Y
    Stroke; 2013 Jun; 44(6):1512-7. PubMed ID: 23640825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Masked hypertension and its associated cardiovascular risk in young individuals: the African-PREDICT study.
    Thompson JE; Smith W; Ware LJ; M C Mels C; van Rooyen JM; Huisman HW; Malan L; Malan NT; Lammertyn L; Schutte AE
    Hypertens Res; 2016 Mar; 39(3):158-65. PubMed ID: 26606873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The complexity of masked hypertension: diagnostic and management challenges.
    Franklin SS; Wong ND
    Curr Hypertens Rep; 2014 Sep; 16(9):474. PubMed ID: 25097111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of ambulatory blood pressure monitoring in assessment of potential living kidney donors.
    Brady NM; Ali H; Biggins F; Ahmed A
    Saudi J Kidney Dis Transpl; 2020; 31(6):1254-1262. PubMed ID: 33565437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of demographic, clinical, and laboratory parameters between patients with sustained normotension, white coat hypertension, masked hypertension, and sustained hypertension.
    Afsar B
    J Cardiol; 2013 Mar; 61(3):222-6. PubMed ID: 23294898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ambulatory Blood Pressure Monitoring in the Diagnosis and Treatment of Hypertension.
    Islam MS
    Adv Exp Med Biol; 2017; 956():109-116. PubMed ID: 27981433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between exercise capacity and masked hypertension in sedentary patients with diabetes mellitus.
    Akilli H; Kayrak M; Arıbas A; Tekinalp M; Ayhan SS; Gündüz M; Alibasic H; Altunbas G; Yazıcı M
    Clin Exp Hypertens; 2014; 36(1):9-16. PubMed ID: 23734826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the Masked Hypertension Study.
    Shimbo D; Newman JD; Schwartz JE
    Am J Hypertens; 2012 Jun; 25(6):664-71. PubMed ID: 22378035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Masked Hypertension: How to Identify and When to Treat?
    Rizzoni D
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):181-6. PubMed ID: 27041372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.